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The brain changes in response to experience and altered environment. This neural plasticity is largely medi-
ated by morphological and functional modification of synapses, a process that depends on both synthesis
and degradation of proteins. It is now clear that regulated proteolysis plays a critical role in the remodeling
of synapses, learning and memory, and neurodevelopment. Here, we highlight the mechanisms and func-
tions of proteolysis in synaptic plasticity and discuss its alteration in disease states.Introduction
Proper protein turnover is critical for maintaining cellular homeo-
stasis and the quality of the cellular proteome. Although essen-
tially all proteins undergo degradation, the process of protein
turnover is tightly controlled at multiple levels. Eukaryotic cells
have evolved elaborate machineries for targeted protein degra-
dation in which the proteolytic active sites are buried inside
a protein chamber (proteasomes) or compartmentalized by
a membrane (lysosomes). A diverse array of regulatory proteins
controls the access of substrate proteins to these degradative
compartments, endowing temporal, spatial, and substrate spec-
ificity to the proteolytic pathways.
Regulated proteolysis is crucial for the health and function of
neurons and for remodeling of synapses during synaptic plas-
ticity, the process by which synaptic connections are modified
in response to past experience and activity. Long-term synaptic
plasticity entails not only functional changes in synaptic strength
but also structural changes in the shape and size of synapses as
well as the physical connectivity of networks. Such modification
of synapses depends on coordinated protein synthesis and
protein degradation events targeting a variety of molecules in
pre- and postsynaptic compartments (Bingol and Schuman,
2005; Yi and Ehlers, 2007). Generally, it is the long-term plasticity
(hour to days), rather than short-term plasticity lasting for
minutes to an hour, that requires synaptic remodeling through
protein synthesis and protein degradation (Tai and Schuman,
2008).
Protein Degradation in Neurons and Synaptic Plasticity
The majority of short-lived proteins in cells are degraded by the
ubiquitin-proteasome system (UPS). Substrate proteins cova-
lently tagged by apolyubiquitin chain are targeted to a proteolytic
organelle—the 26S proteasome—for degradation. The other
main degradation system is the lysosome, which contains mul-
tiple proteases and accounts for 20% of protein turnover in
cells (Ciechanover, 2006). Lysosomes mainly degrade organ-
elles and membrane proteins. Cytoplasmic proteins can also
be degraded through autophagy, a process in which organelles
and bulk cytoplasm are enveloped in double membranes and22 Neuron 69, January 13, 2011 ª2011 Elsevier Inc.then delivered to lysosomes (Wong and Cuervo, 2010). Defects
in any of these proteolytic pathways are associated with a
growing list of human diseases. In particular, many neurodegen-
erative disorders such as Alzheimer disease (AD) and Parkinson
disease (PD) show accumulation of toxic protein aggregates in
neurons and evidence of defective protein clearance.
Early evidence of a link between protein degradation and syn-
aptic plasticity and learning came from Aplysia, where repeated
stimulation of sensory neurons by serotonin induces a form of
synaptic plasticity termed long-term-facilitation (LTF), thought
to underlie the desensitization of the gill withdrawal reflex (Hegde
et al., 1993). LTF depends on persistent activation of protein
kinase A (PKA), which is mediated by proteasomal degradation
of the PKA regulatory subunit—a negative regulator of the kinase
(Chain et al., 1999; Hegde et al., 1993). Activated PKA induces
transcription of many genes, one of which is ApUCH (UCH-L1
in mammals)—a deubiquitinating enzyme that recycles free
ubiquitin and facilitates degradation of proteasome substrates,
including the PKA regulatory subunit (Hegde et al., 1997).
ApUCH provides an important positive feedback mechanism
to maintain PKA activity, because without ApUCH function,
LTF is impaired (Hegde et al., 1997). Thus, in LTF, protein degra-
dation enhances synaptic strength by removing a repressor of
a signaling pathway.
The UPS is also critical for learning andmemory in vertebrates.
In rodents, bilateral injection of proteasome inhibitor lactacystin
into the CA1 region of the hippocampus blocks long-term mem-
ory formation in a one-trial inhibitory avoidance task (Lopez-
Salon et al., 2001). Similarly, extinction of fear memory and
consolidation and reconsolidation of spatial memory depend
on proteasome activity (Artinian et al., 2008; Lee et al., 2008).
Consistent with the need for UPS-mediated degradation, levels
of ubiquitinated synaptic proteins increase in the hippocampus
following one-trial inhibitory avoidance task (Lopez-Salon
et al., 2001) and retrieval of fear memory (Lee et al., 2008).
Synaptic plasticity in mammals requires proteasome func-
tion. Long-term depression (LTD) in hippocampus, a well-
studied model of synaptic weakening associated with synapse
shrinkage, partially depends on proteasome activity (Colledge
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some function is also crucial for the strengthening of synapses.
Early and late phases of long-term potentiation (LTP) in CA1
region of the hippocampus are impaired by the proteasome
inhibitor MG132 (Karpova et al., 2006). In another study using
a more specific inhibitor of the proteasome (lactacystin), early-
phase LTP was enhanced but late-phase LTP was blocked
(Dong et al., 2008). Interestingly, concomitant inhibition of pro-
tein synthesis and degradation did not alter LTP, suggesting an
interplay between these opposing processes in this form of plas-
ticity (Fonseca et al., 2006). Taken together, these studies
indicate that the UPS is essential to carry out the synaptic modi-
fications associated with plasticity and learning and memory in
diverse organisms.
Components of the Ubiquitin-Proteasome System
Substrate proteins destined to be degraded by the 26S protea-
some are first ubiquitinated via a series of enzymatic reactions
involving ubiquitin-activating (E1), conjugation (E2), and ligase
(E3) enzymes (Ciechanover, 2006). E2 enzymes are character-
ized by a conserved ubiquitin-conjugating (UBC) domain and
a catalytic cysteine residue. E2 enzymes, in conjunction with
E3 ubiquitin ligases, form substrate binding surfaces to carry
out ubiquitination. Two major classes of E3 enzymes are RING
domain E3s and HECT domain-containing E3 enzymes. Most
HECT-type E3s, and some RING-type ligases such as parkin,
function as monomers. Other E3s exist as multiprotein com-
plexes with modular subunits that include a core scaffold protein
that interacts with a RING domain E3 and an adaptor protein that
binds and recruits the substrate to be ubiquitinated. A well-
studied example is the SCF complex composed of Skp1 linker,
Cullin scaffold, and one of a variety of F-Box proteins (e.g.,
b-TRCP) that recruits the substrates to the RING domain E3
(Nagy and Dikic, 2010). There are two E1, 50 E2, and 500
E3 enzymes in the human genome; thus the substrate specificity
of ubiquitination is mainly determined by different combinations
of E2–E3 complexes (Ciechanover, 2006).
E3 enzymes can add a single ubiquitin molecule to the
acceptor lysine residue of the substrate (monoubiquitination) or
they can add ubiquitin monomers sequentially to form a polyubi-
quitin chain (Nagy and Dikic, 2010). Monoubiquitination does not
signal for proteasomal degradation but rather seems to regulate
protein trafficking and other processes. The outcome of polyubi-
quitination depends on which lysine residue of the seven present
in ubiquitin is utilized for constructing the chain. Lysine-48 (K48)-
linked polyubiquitin chains target proteins for proteasomal
degradation, whereas K63 chains are used for nonproteasomal
functions such as protein kinase activation, regulation of protein-
protein interactions, and control of receptor endocytosis (Nagy
and Dikic, 2010). By utilizing different lysine residues, the ubiqui-
tination system can generate diverse polyubiquitin structures
and varied signaling outcomes, which are still not fully under-
stood in neurons or other cell types.
Once a substrate is ubiquitinated by K48 chains, it is conveyed
to the 26S proteasome by E3s themselves, substrate-shuttling
factors, or binding to resident polyubiquitin receptors on the pro-
teasome (Glickman and Raveh, 2005). Both in neurons and non-
neuronal cells, proteasome activity and subcellular localizationcan be dynamically modulated through posttranslational modifi-
cations and regulated interactions with accessory proteins, such
as CaMKIIa (Bingol and Schuman, 2006; Bingol et al., 2010; Dja-
kovic et al., 2009; Glickman and Raveh, 2005). There is also
evidence for different proteasome-interacting proteins in brain
versus other tissues and even between synaptic versus cytosolic
compartments within neurons, suggesting proteasome hetero-
geneity across cell types and subcellular compartments (Tai
et al., 2010).
Protein ubiquitination is a dynamic and reversible process
owing to the action of deubiquitinating enzymes (DUBs; 100
in the human genome) (Komander et al., 2009). DUBs can both
facilitate and antagonize ubiquitin-mediated signaling and
protein degradation. They promote ubiquitination in general by
providing free ubiquitin through cleavage of ubiquitin monomers
from polyubiquitin chains. On the other hand, DUBs counteract
the function of E3 ligases and stabilize proteins by removing
ubiquitin from substrates before they can be destroyed by the
proteasome. DUBs can also remove monoubiquitin and other
types of polyubiquitin linkages (such as K63-polyubiquitin)
to terminate proteasome-independent ubiquitin signaling
(Komander et al., 2009).
UPS and Synaptic Function
To date, several ubiquitin conjugation and removal enzymes
have been described that regulate synaptic function (see
Tables 1 and 2 and Figure 1). Below, we summarize these mole-
cules with a focus on mammalian systems. An excellent review
covers degradation systems in invertebrates (Hegde, 2010).
One of the first E3 ligases implicated in synaptic plasticity and
postsynaptic function was E6-AP (also known as UBE3A),
a HECT domain-containing E3 ligase (Jiang et al., 1998). E6-AP
is encoded by a maternally-imprinted gene, Ube3A, inactivating
mutations of which lead to a neurodevelopmental disorder
called Angelman syndrome (AS) (Kishino et al., 1997; Matsuura
et al., 1997). Loss of UBE3A function in a mouse model of
AS impairs LTP and contextual learning (Jiang et al., 1998).
CaMKIIa—a major enzyme required for plasticity and learning
and memory—is decreased in abundance and activity in post-
synaptic densities (PSDs) of UBE3A mice, perhaps explaining
the plasticity and learning deficits (Weeber et al., 2003). Remark-
ably, these molecular and behavioral defects in UBE3A mice are
completely rescuedby introducingmutations in the phosphoryla-
tion sites of CaMKIIa that negatively regulate its activity and syn-
aptic abundance (T305/T306) (van Woerden et al., 2007). The
mechanism of CaMKIIa regulation by UBE3A remains unclear.
Recent studies showed that UBE3A directly ubiquitinates Arc,
an activity-induced protein that promotes the internalization of
the AMPA-type glutamate receptors (AMPARs) (Greer et al.,
2010), thus providing another example of degradation of a nega-
tive regulator of synaptic strength. Disruption of UBE3A function
stabilizes Arc protein and reduces the number of AMPARs at
excitatory synapses. Because AMPARs play a central role in
excitatory synaptic transmission and plasticity, deregulation of
Arc and surface AMPARs offers a plausible mechanism for the
deficits observed in AS.
Homeostatic synaptic plasticity operates over a time scale of
hours to days to maintain synaptic strength within a dynamicNeuron 69, January 13, 2011 ª2011 Elsevier Inc. 23
Table 1. Examples of Substrates and Functions of Ubiquitin Ligases and DUBs in Mammalian Neurons
Function Substrate Reference
Ubiquitin Ligases
UBE3A (E6-AP) Regulation of glutamate receptor trafficking
and CaMKII abundance in PSD;
Loss of function in Angelman syndrome
Arc Greer et al., 2010; Jiang et al., 1998;
Weeber et al., 2003
TRIM3 Activity-dependent postsynaptic remodeling GKAP Hung et al., 2010
APC Negative regulator of axon growth Liprin-a Konishi et al., 2004
b-TRCP Regulation of dendritic spine morphology SPAR Ang et al., 2008
Rnf6 Axonal growth - local regulation of actin
dynamics in growth cones
LIM kinase 1 Tursun et al., 2005
Nedd4 Dendrite and axon branching PTEN,
Rap2
Drinjakovic et al., 2010;
Kawabe et al., 2010
Mdm2 Glutamate receptor trafficking PSD-95 Colledge et al., 2003
Fbx2 Homeostatic control of NMDARs NR1 Kato et al., 2005
Parkin Neuroprotection;
Clearance of damaged mitochondria
through mitophagy
Synphilin, a-synuclein,
synaptotagmin XI, the
Pael receptor, cyclin E,
tubulin, p38/JTV-1, Eps15,
VDAC, mitofusin
Reviewed in Hegde, 2010
Phr-1 Neuronal polarity maintenance Lewcock et al., 2007; Bloom et al., 2007
DUBs
UCH-L1 Maintenance of free ubiquitin pool;
Turnover of postsynaptic scaffolds
Cartier et al., 2009; Saigoh et al., 1999
USP14 Maintenance of free ubiquitin pool Chen et al., 2009
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ticity also depends on UPS-mediated degradation. Chronic
increases or decreases in neuronal activity induce protea-
some-dependent reciprocal changes in the abundance of
numerous proteins in the PSD (Ehlers, 2003). However, only
a few proteins were found to be directly ubiquitinated in the
PSD, suggesting that UPS may target specific ‘‘master orga-
nizers’’ of the PSD to regulate a larger set of associated postsyn-
aptic proteins. Indeed, Shank1 and GKAP are highly ubiquiti-
nated and activity-regulated core scaffold proteins of the PSD,
organizing cytoskeletal/signaling complexes and maintainingTable 2. Examples of Ubiquitinated Neuronal Proteins Where the
Ubiquitin Ligase Is Not Identified
Substrate Function Reference
Shank Postsynaptic scaffold Ehlers, 2003
GABA-A
Receptor b3
Inhibitory neurotransmitter
receptor
Saliba et al., 2007
Glycine
Receptor
Inhibitory neurotransmitter
receptor
Bu¨ttner et al., 2001
Synaptophysin Neurotransmitter release Wheeler et al., 2002
Syntaxin-1 Neurotransmitter release Chin et al., 2002
Liprin-a Presynaptic and
postsynaptic
scaffold
Hoogenraad et al., 2007
MOV10 Translation repressor Banerjee et al., 2009
GRIP1 Postsynaptic scaffold Guo and Wang, 2007
AKAP79/150 Postsynaptic scaffold Ehlers, 2003
24 Neuron 69, January 13, 2011 ª2011 Elsevier Inc.synaptic morphology (Ehlers, 2003; Sheng and Kim, 2000).
Recently a RING domain ubiquitin ligase, TRIM3, was identified
as a specific E3 ligase for GKAP in hippocampal neurons (Hung
et al., 2010). TRIM3mediates activity-induced ubiquitination and
downregulation of GKAP and causes concomitant decreases
in Shank1 abundance and synaptic size (Hung et al., 2010).
Because degradation of GKAP and Shank occurs during
memory consolidation and reconsolidation (Lee et al., 2008), it
would be interesting to know how plasticity and memory is
affected in animals without TRIM3.
How does neuronal activity control turnover of postsynaptic
proteins? Ubiquitination and phosphorylation are often linked
(Hunter, 2007). Ubiquitination is frequently preceded by phos-
phorylation of a specific motif on the substrate (called a degron),
which then recruits the ubiquitination machinery. In neurons,
synaptic activity could induce phosphorylation of these degrons
and prime substrates for UPS degradation, as exemplified by
the turnover of a postsynaptic spine-associated Rap GTPase-
activating protein (SPAR) (Ang et al., 2008). Following neuronal
stimulation, SPAR gets phosphorylated by an activity-induced
protein kinase, Polo-like kinase 2 (Plk2) (Pak and Sheng, 2003),
which creates a phospho-degron that mediates the physical
interaction of SPAR with b-TRCP, an F-box component of a
SCF E3 complex (Ang et al., 2008). Functionally, SPAR degrada-
tion mediated by Plk2 and the UPS is necessary for homeostatic
dampening of synaptic strength following prolonged elevation
of activity (Seeburg et al., 2008). SPAR degradation is another
example of proteolysis of a negative regulator of signaling,
in this case leading to enhanced Rap activity and synapse
weakening.
Figure 1. Examples of Presynaptic and
Postsynaptic Proteins Targeted by the UPS
and, Where Known, the Ubiquitin Ligases
Responsible for their Ubiquitination
Presynaptic and postsynaptic proteins are in blue
and ubiquitin ligases are in red.
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number of postsynaptic AMPARs, mechanisms that target
AMPARs or AMPAR trafficking are of great interest. AMPARs
undergo endocytosis in response to direct agonist binding
or activation of N-methyl-D-aspartic acid receptors (NMDARs),
and both processes require proteasome activity (Colledge
et al., 2003; Patrick et al., 2003). Although AMPAR homologs in
invertebrates were reported to be ubiquitinated and regulated
by UPS, it is not clear whether mammalian AMPARs are directly
ubiquitinated (Bingol and Schuman, 2004; Burbea et al., 2002;
Colledge et al., 2003; Patrick et al., 2003).
The UPS also regulates presynaptic function. In cultured
hippocampal neurons, proteasome inhibition for 2 hr increases
the size of the recycling vesicle pool by 75% without changing
the release probability, suggesting that proteasomal degrada-
tion controls synaptic vesicle cycling (Willeumier et al., 2006).
What are the targets of proteasome in mammalian presynaptic
terminals? In hippocampal acute slices, proteasome inhibitors
increase the frequency of miniature excitatory postsynaptic
currents (mEPSC), an effect that depends on SCRAPPER, an
F-box protein localized to presynaptic membranes (Yao et al.,
2007). SCRAPPER mediates the ubiquitination and degradation
of the presynaptic vesicle priming factor, RIM1. In slices
prepared from SCRAPPER knockout mice, RIM1 escapes pro-
teasome degradation, and its accumulation is sufficient to
occlude enhancement of mEPSCs by proteasome inhibitors.
Thus, proteasome activity seems to limit vesicle release by de-
grading RIM1 ubiquitinated by SCRAPPER (Yao et al., 2007).
However, another study found that in cultured hippocampal
neurons, proteasome inhibition increases mEPSC frequency
without causing a buildup of RIM1 (Rinetti and Schweizer,
2010). Because RIM1 degradation is induced by elevated activity
in neuronal cultures (Jiang et al., 2010), it is possible that under
basal culture conditions RIM1 stays stable and proteasome
inhibition affects presynaptic function via RIM1-independent
mechanisms.Neuron 6A number of E2s and DUBs are re-
ported to be essential for synaptic func-
tion and development. A mutation in fly
E2 enzyme bendless leads to impaired
jump response due to aberrant synaptic
connectivity between the giant fiber neu-
ron and its muscle target (Muralidhar
and Thomas, 1993). Synaptic defects in
ataxia mutant mice (characterized by
hind limb paralysis, resting tremor, and
postnatal lethality) result from mutations
in a DUB, Usp14. Usp14 encodes for
a proteasome-associated ubiquitin pro-
tease that may function in disassemblingpolyubiquitin chains, thereby providing free ubiquitin for the UPS
(Wilson et al., 2002). UCH-L1, a homolog of Aplysia UCH,
promotes proteasomal degradation and turnover of postsyn-
aptic scaffolds such as PSD-95 by generating free ubiquitin
(Cartier et al., 2009). UCH-L1may also be associated with neuro-
degenerative disorders (see below).
Regulation of UPS by Neuronal Activity
How does neuronal activity influence UPS function? Fluores-
cence-based degradation reporters indicate that proteasome
activity rises in response to LTP-inducing stimuli in hippocampal
slices and following NMDAR activation in dissociated neuron
cultures (Bingol and Schuman, 2006; Djakovic et al., 2009;
Karpova et al., 2006). Chronic elevation of neuronal activity
increases levels of ubiquitinated proteins in the PSD; decreased
neuronal activity has the opposite effect (Ehlers, 2003). CaMKIIa,
a postsynaptic kinase activated by calcium entry through
NMDARs, phosphorylates and enhances proteolytic activity of
the proteasome, linking synaptic excitation to local stimulation
of the UPS (Bingol et al., 2010; Djakovic et al., 2009).
The subcellular location of proteasomes in neurons is also
regulated by activity (Bingol and Schuman, 2006; Bingol et al.,
2010; Shen et al., 2007). Proteasomes rapidly redistribute from
dendritic shaft to dendritic spines in response to activation
of NMDARs; this redistribution is mediated by binding of protea-
somes to activated CaMKIIa (Bingol et al., 2010). Because
CaMKIIa translocates to the PSD of stimulated synapses and
is itself critical for potentiation of synaptic strength, proteasome
recruitment by CaMKIIa provides a mechanism for localizing the
effects of proteasome degradation specifically to activated
synapses undergoing plasticity. A cocaine-induced protein,
NAC1, may also be involved in recruitment of proteasomes to
dendrites and dendritic spines (Shen et al., 2007). In addition
to subcellular localization, the biochemical composition of pro-
teasomes appears to be dynamic and subject to control by
neuronal activity (Tai et al., 2010).9, January 13, 2011 ª2011 Elsevier Inc. 25
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and Plasticity
Hebbian forms of plasticity are believed to result from modifica-
tions localized to a specific subset of synapses. Thus, synapses
must utilize the products of protein synthesis and confine
the effects of proteolysis in a synapse-specific manner. Indeed,
ribosomes and proteasomes are present at or near postsyn-
aptic sites where they could act locally to make or break down
proteins (Bingol and Schuman, 2006; Bourne and Harris, 2008;
Sutton and Schuman, 2006). Local protein degradation by UPS
operates in growth cones to guide the navigation of axons
(Campbell and Holt, 2001; Verma et al., 2005). In support of
compartment-specific functions of the UPS, blocking protea-
some activity in Aplysia throughout the neuron blocks potentia-
tion, whereas proteasome inhibition specifically around syn-
apses has the opposite effect on plasticity (Chain et al., 1999;
Hegde, 2004; Zhao et al., 2003). In addition to protein degrada-
tion, local protein synthesis is central for plasticity (Cajigas et al.,
2010). Interestingly, protein synthesis can be activated through
degradation of a negative regulator of translation, the RISC
complex, releasing translationally suppressed synaptic mRNAs
for local protein synthesis (Ashraf et al., 2006; Banerjee et al.,
2009).
Local proteolysis is important during neurodevelopmental
processes, such as dendrite pruning. During larval metamor-
phosis, Drosophila sensory neuron dendrite pruning requires
UPS components E1, an E2 called ubcD1, and the proteasome,
as well as caspase activity (Kuo et al., 2005, 2006). Interestingly,
ubcD1 downregulates an E3 ubiquitin ligase, DIAP-1, and in turn
DIAP-1 targets a proapoptotic caspase (Dronc) required for
dendritic pruning. Caspase activity reporters indicate that Dronc
caspase activity is confined to degenerating dendrites of pruning
neurons, consistent with the idea that local degradation of
DIAP-1 stabilizes Dronc in dendrites destined for destruction
(Kuo et al., 2006;Williams et al., 2006). Importantly, these studies
not only identify E2/E3 enzymes essential for dendritic pruning
but also provide a mechanistic link between the UPS and cas-
pases in a nonapoptotic context. Extending the theme of UPS
and caspase involvement in remodeling of neuronal processes,
UPS and caspases also appear to function in a spatially-
restricted manner during pruning of fly axons and degeneration
of mammalian axons (Nikolaev et al., 2009; Watts et al., 2003).
A nonapoptotic requirement for caspase-mediated proteol-
ysis was also shown for synaptic plasticity (Li et al., 2010).
Specifically, LTD and AMPAR internalization require activation
of caspase-3 via themitochondrial pathway of apoptosis. Chem-
ically induced LTD was associated with transient and modest
activation of caspase-3 in dendrites, but not cell death, implying
that caspase-3 activity can be localized to or near synaptic sites
without culminating in neuronal apoptosis (Li et al., 2010). Unlike
the UPS or lysosomes, caspases probably act by sequence-
specific cleavage—rather than degradation—of a select set of
target proteins. The molecular mechanism by which caspase
effects are restricted to specific neuronal compartments
(perhaps even specific synapses) is an important unanswered
question.
Local breakdown of proteins—and selective pruning of
synapses—can additionally be achieved by spatiotemporal26 Neuron 69, January 13, 2011 ª2011 Elsevier Inc.control of E3 ligase assembly. In Caenorhabditis elegans, local-
ized inhibition of the assembly of an SCF complex through
binding of core protein SKR-1 to a synaptic adhesion molecule,
SYG-1, spares synapses from elimination (Ding et al., 2007). It is
unknown whether synapse elimination in mammals also relies
on local regulation of E3 ubiquitin ligase.
The morphological sculpting of certain synapses is regulated
by an evolutionarily conserved RING domain E3 ligase Phr1
(also known as Highwire in Drosophila, and RPM-1 inC. elegans)
(Schaefer et al., 2000; Wan et al., 2000; Zhen et al., 2000).
In mammals, Phr1 functions to sculpt motor nerve terminals
and is essential for formation of major CNS axon tracts (Bloom
et al., 2007). Interestingly, in mice, Phr1 is localized to the axonal
shaft and excluded from growth cones, where the protein kinase
DLK is restricted (Lewcock et al., 2007). In the absence of Phr1,
DLK aberrantly distributes to axons, leading to altered microtu-
bule dynamics and axon-pathfinding deficits. Based on the
reciprocal localization of DLK and Phr1, DLK was proposed as
a Phr1 substrate, similar to the scenario in invertebrates (Collins
et al., 2006; Lewcock et al., 2007; Nakata et al., 2005). However,
no increase in DLKwas detected in the central nervous system of
Phr1 mutant mice and DLK is not required for Phr1 loss-of-func-
tion phenotypes (Bloom et al., 2007). In fish, Phr1 localizes to
growth cones and regulates pathfinding independent of DLK
(Hendricks and Jesuthasan, 2009). Collectively, these studies
demonstrate that despite possible cell-type or species-specific
differences in the regulation of Phr1, this ubiquitin ligase regu-
lates microtubule remodeling during development and is crucial
for axon navigation.
HECT domain Nedd4 is another ubiquitin ligase acting in
axons; it promotes branching by targeting PTEN, a PIP3 phos-
phatase that negatively regulates axonal branching (Drinjakovic
et al., 2010). Remarkably, Nedd4 also enhances the branching
of dendrites by monoubiquitinating GTPase Rap2 and inhibiting
its function (Kawabe et al., 2010). Thus an E3 ligase can target
different substrates in different subcellular compartments to
carry out similar cell biological functions.
Other Proteolytic Pathways Important for Synaptic
Plasticity and Function
Neurons also utilize the lysosome system to degrade organelles
and synaptic proteins. For example, following endocytosis,
AMPARs either recycle back to the membrane or are sorted
into lysosomes, depending on their subunit composition and
whether AMPARs themselves or NMDARs were activated
(Ehlers, 2000; Lee et al., 2004).
Organelles and cytoplasmic proteins can also be targeted
to lysosomal degradation through autophagy (‘‘self-eating’’).
The canonical autophagy pathway involves sequestration of
substrates into double-membrane structures called autophago-
somes (APs) and delivering APs to lysosomes for degradation
(Wong and Cuervo, 2010). Autophagy can nonselectively
degrade bulk cytoplasm and organelles (macroautophagy)
or may involve chaperones that mediate selective fusion of
substrates with lysosomes (chaperone-mediated autophagy).
Autophagy could contribute to remodeling of synapses and
neurites in neurons. In C. elegans, endocytosed GABA-A
receptors, but not acetylcholine receptors, are targeted to
Neuron
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structures accumulate in axons of autophagy-deficient mice
(Komatsu et al., 2007). In flies, autophagy promotes synapse
growth by downregulating Highwire (Shen and Ganetzky,
2009). As discussed below, failure to degrade proteins and
organelles due to defects in autophagy may be one of the
pathogenic mechanisms associated with neurodegenerative
diseases.
The growth and retraction of neuronal processes and the
making and breaking of neuronal contacts not only involves re-
modeling of intracellular structures but also the brain extracel-
lular matrix (ECM). ECM components have profound influences
on neuronal signaling, adhesion, and motility and are subject
to regulated proteolysis during plasticity (Dityatev, 2010). Gener-
ally, the mature ECM environment seems inhibitory for structural
plasticity. Chondrotin sulfate proteoglycans appear to be one
of the inhibitory components in ECM because their degradation
by chondroitinase-ABC can reactivate ocular dominance plas-
ticity (Pizzorusso et al., 2002). Supporting an essential role of
ECM remodeling in structural plasticity, the matrix metallopro-
tease (MMP)-9 is required for spine enlargement that accom-
panies LTP (Wang et al., 2008). Furthermore, pharmacological
or genetic inhibition of MMP-9 impairs LTP and prevents spatial
learning (Bozdagi et al., 2007; Meighan et al., 2006), whereas
addition of recombinant-active MMP-9 is sufficient to potentiate
synapses and occlude further LTP (Bozdagi et al., 2007; Nagy
et al., 2006).
Proteolysis and Neurodegenerative Diseases
The aggregation and deposition of misfolded proteins is a hall-
mark of neurodegenerative diseases and may reflect the failure
of cellular protein clearance mechanisms. These pathological
protein aggregates include plaques and tangles in AD, Lewy
bodies in PD, polyglutamine inclusion bodies in Huntington
disease, and TDP-43 inclusions in amyotrophic lateral sclerosis
(ALS). Whether these aggregates are the primary cause of the
neurodegeneration or secondary by-products remains contro-
versial.
Since intracellular inclusions associated with neurodegenera-
tive diseases are rich in ubiquitinated proteins, it was suggested
that these diseases are associated with impaired proteasome
function in neurons (Ross and Poirier, 2004). Autophagy also
plays a role in the degradation of protein aggregates and inmain-
taining proteostasis (Wong andCuervo, 2010). Disruption inmice
of key autophagy genes, such as Atg7 or Atg5, causes neurode-
generation and ubiquitin-rich inclusions (Hara et al., 2006;
Komatsu et al., 2006). The neurodegeneration is associated
with accumulation of aberrant organelles and stacks of cisternal
membranes in the dystrophic axons of autophagy-deficient
neurons (Komatsu et al., 2007). Consistent with a protective
function of autophagy, pharmacological enhancement of au-
tophagy can rescue neurons from the toxicity associated with
aggregated misfolded proteins or proteasome inhibition (Pan
et al., 2008; Pandey et al., 2007; Tsvetkov et al., 2010).
Neurodegenerative diseases—which involve death of neu-
rons, degeneration of axons, loss of synapses, and impairment
of synaptic plasticity—may be a pathological manifestation of
cellular processes that are used normally in development, suchas apoptosis, neurite pruning, and synapse elimination. In this
context, it is interesting that molecular players in physiological
plasticity and pathological neurodegeneration are often shared,
such as the involvement of proteolytic caspase-3 in LTD and
neuronal cell death (Li et al., 2010). In this section, we will focus
on how proteolytic pathways are dysregulated in AD and PD.
Alzheimer Disease
AD is characterized by protein deposits composed of Ab peptide
(plaques) and hyperphosphorylated tau (tangles), both of which
probably contribute to synaptic dysfunction and neuronal
death (Ross and Poirier, 2004). In AD brains, ubiquitin immuno-
reactivity accumulates in intracellular aggregates suggesting
UPS dysfunction (Chu et al., 2000). Reduced proteasome activity
is reported in brain regions affected by AD, such as the hippo-
campus (Keck et al., 2003; Keller et al., 2000). Similarly, primary
neurons isolated from APP transgenic mice show decreased
proteasome activity (Almeida et al., 2006). Interestingly, trans-
duction of UCH-L1, a DUB that promotes proteasomal degrada-
tion, reverses behavioral deficits in AD model mice (Gong et al.,
2006; Smith et al., 2009), consistent with an impairment of UPS in
AD. Overexpression of an anomalous form of ubiquitin found
in some AD patients (UBB+1; generated by a non-DNA-encoded
dinucleotide deletion in ubiquitin transcripts) impairs proteaso-
mal degradation and induces neuronal death (Lam et al., 2000;
Tan et al., 2007).
Defective proteasomal degradation of hyperphosphorylated
tau may contribute to the buildup of tangles. Tau interacts with
CHIP, an E3 ubiquitin ligase required for degradation of soluble
phosphorylated tau (Dickey et al., 2006; Shimura et al., 2004).
In AD, the mechanism of stabilization and accumulation of
hyperphosphorylated taumay involve inhibition of tau interaction
with CHIP (Dickey et al., 2006). In addition to phosphorylation,
tau is also acetylated; acetylation impairs the proteosomal
degradation and enhances the accumulation of tau (Min et al.,
2010).
Impairment of autophagy is also implicated in AD. Ab may
directly impair lysosomal degradation of autophagic cargo
(Ling et al., 2009). Presenilin-1 mutations that cause early-onset
AD result in defective lysosomal acidification and autophagy,
which might contribute to accumulation of toxic proteins and
neurodegeneration (Lee et al., 2010a). Degenerating neurites in
AD contain large numbers of intermediate structures of autoph-
agy (autophagic vacuoles), implying deficient autophagic clear-
ance (Boland et al., 2008). These intermediate structures may
act as sources of pathogenic Ab peptide since they harbor the
amyloid precursor protein (APP) along with the proteases that
cleave APP to produce Ab (Yu et al., 2005). Furthermore, in
a mouse model of AD, genetic reduction of Beclin-1, a compo-
nent of the autophagy pathway, promotes formation of plaques
and neurodegeneration (Pickford et al., 2008). In culture, knock-
down of Beclin-1 leads to accumulation of APP and increased
secretion of Ab (Jaeger et al., 2010). Antagonizing IGF-1 receptor
signaling (a negative regulator of autophagy) in AD mice amelio-
rates cognitive defects and neuronal loss (Cohen et al., 2009).
Parkinson Disease
Although more than 95% of PD cases are sporadic, hereditary
and sporadic forms of PD share common pathologies that could
be linked to UPS dysfunction (Vila and Przedborski, 2004).Neuron 69, January 13, 2011 ª2011 Elsevier Inc. 27
Figure 2. Schematic Diagram of the Degradation of Neuronal Proteins in Synaptic Plasticity
A representation of various proteolytic pathways that regulate synaptic function and plasticity (see text for details). Red arrows indicate proteolytic events and
black dashed arrows indicate translocation of the indicated structures. Blue arrows indicate events downstream of glutamate receptor activation. Synaptic
activity and stimulation of NMDARs triggers ubiquitination of synaptic proteins, recruitment of proteasomes to spines, internalization of AMPARs, and activation
of caspases and calpains (Wu and Lynch, 2006). Misfolded proteins and defective mitochondria are cleared through the autophagy pathway. Internalized surface
proteins such as AMPARs are degraded in lysosomes or via multivesicular bodies (MVBs). MVBs and misfolded proteins can be transported to the cell soma by
dynein-mediated retrograde transport, involving HDAC6 (Pandey et al., 2007). Extracellular proteases such as tPA, plasminogen, and MMPs proteolyse ECM
components and remodel ECM during plasticity.
Neuron
ReviewSelective inactivation of 26S proteasomes in substantia nigra
dopaminergic neurons in a conditional knockout mouse model
results in neurodegeneration and ubiquitin-positive aggregates
resembling Lewy bodies (Bedford et al., 2008). Pathogenic forms
of a-synuclein, a principal constituent of Lewy bodies, can
directly bind to proteasomes and inhibit their activity (Lindersson
et al., 2004; Snyder et al., 2003). More significantly, loss-of-func-
tion mutations in parkin—an E3 ligase with two RING domains—
underlie a recessively inherited early onset form of PD (Kitada
et al., 1998). Interestingly, PD patients with parkin mutations
lack Lewy bodies, suggesting that parkin may be required
for formation and ubiquitination of these protein aggregates.
Parkin could confer neuroprotection by promoting prosurvival
signaling through PI(3)K-Akt pathway (Fallon et al., 2006), target-
ing cyclin E (a prodeath factor in neurons) (Staropoli et al., 2003),
and promoting clearance of protein aggregates and unfolded
proteins (Dauer and Przedborski, 2003). Recent studies point
compellingly to a role for parkin (and another gene for familial
PD—the protein kinase PINK1) in the clearance of damaged
mitochondria through autophagy (mitophagy) (Narendra et al.,
2008). PINK1 becomes stabilized on damaged mitochondria
and recruits parkin (Narendra et al., 2010). Parkin ubiquitinates28 Neuron 69, January 13, 2011 ª2011 Elsevier Inc.proteins on damaged mitochondria through K63 and K27 link-
ages with subsequent recruitment of p62, an adaptor protein
that links ubiquitinatedmitochondria to themitophagymachinery
(Geisler et al., 2010). Without quality control by parkin, defective
mitochondria accumulate, leading to neuronal dyshomeostasis
and cell death (Geisler et al., 2010; Kawajiri et al., 2010; Lee
et al., 2010b; Matsuda et al., 2010; Michiorri et al., 2010; Naren-
dra et al., 2008, 2010; Vives-Bauza and Przedborski, 2010).
PD may also be associated with a general defect in lysosomal
degradation. In PD postmortem brains, there is a reduction in
lysosomes and an accumulation of autophagosomes (Dehay
et al., 2010). a-synuclein is a substrate of chaperone-mediated
autophagy (Vogiatzi et al., 2008) and PD-linkedmutants or dopa-
mine-modified forms of a-synuclein act as lysosomal uptake
blockers, impairing its own degradation and that of other lyso-
some substrates (Cuervo et al., 2004; Martinez-Vicente et al.,
2008).
Future Directions
This review highlights the diversity and importance of proteolytic
pathways in synapse development, synaptic plasticity, and the
maintenance of neuronal health (Figure 2). The destruction of
Neuron
Reviewproteins—which can result in either loss- or gain-of-signaling
pathway functions—has generally received less attention than
the production of proteins in the control of neural plasticity.
In most cases of proteolytic control, the details of the regulation
(when and how proteolysis is activated) and the molecular
mechanisms (for instance, which particular substrates are
important and which specific E3s are responsible) have yet to
unfold. Of special interest is how protein degradation events
are confined to specific compartments such as synapses,
dendrite branches, and axon growth cones. It would not be
surprising if different proteolytic pathways regulate each other
to achieve spatial and temporal specificity of protein turnover.
Another major question is how the destruction of existing
proteins is coordinated with the synthesis and delivery of
new proteins to achieve remodeling of neurons and their
connections.
Recent studies suggest a protective role of autophagy in
neurons, but we know very little about the physiological roles
of this process in mature neurons and whether it is involved in
plasticity to remodel neurites and synapses. How autophagy
interacts functionally with the UPS and other proteolytic systems
in neurons is also unclear. Understanding the roles and mecha-
nisms of regulated protein turnover in the health and plasticity of
neurons promises to bring valuable insights into the pathogen-
esis of common neurodegenerative diseases.ACKNOWLEDGMENTS
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